Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative

Data collected as part of routine clinical practice could be used to detect cardiovascular outcomes in pragmatic clinical trials or clinical registry studies. The reliability of claims data for documenting outcomes is unknown. We linked records of Women's Health Initiative (WHI) participants ag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation Cardiovascular quality and outcomes 2014-01, Vol.7 (1), p.157-162
Hauptverfasser: Hlatky, Mark A, Ray, Roberta M, Burwen, Dale R, Margolis, Karen L, Johnson, Karen C, Kucharska-Newton, Anna, Manson, JoAnn E, Robinson, Jennifer G, Safford, Monika M, Allison, Matthew, Assimes, Themistocles L, Bavry, Anthony A, Berger, Jeffrey, Cooper-DeHoff, Rhonda M, Heckbert, Susan R, Li, Wenjun, Liu, Simin, Martin, Lisa W, Perez, Marco V, Tindle, Hilary A, Winkelmayer, Wolfgang C, Stefanick, Marcia L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 162
container_issue 1
container_start_page 157
container_title Circulation Cardiovascular quality and outcomes
container_volume 7
creator Hlatky, Mark A
Ray, Roberta M
Burwen, Dale R
Margolis, Karen L
Johnson, Karen C
Kucharska-Newton, Anna
Manson, JoAnn E
Robinson, Jennifer G
Safford, Monika M
Allison, Matthew
Assimes, Themistocles L
Bavry, Anthony A
Berger, Jeffrey
Cooper-DeHoff, Rhonda M
Heckbert, Susan R
Li, Wenjun
Liu, Simin
Martin, Lisa W
Perez, Marco V
Tindle, Hilary A
Winkelmayer, Wolfgang C
Stefanick, Marcia L
description Data collected as part of routine clinical practice could be used to detect cardiovascular outcomes in pragmatic clinical trials or clinical registry studies. The reliability of claims data for documenting outcomes is unknown. We linked records of Women's Health Initiative (WHI) participants aged ≥65 years to Medicare claims data and compared hospitalizations that had diagnosis codes for acute myocardial infarction or coronary revascularization with WHI outcomes adjudicated by study physicians. We then compared the hazard ratios for active versus placebo hormone therapy based solely on WHI-adjudicated events with corresponding hazard ratios based solely on claims data for the same hormone trial participants. Agreement between WHI-adjudicated outcomes and Medicare claims was good for the diagnosis of myocardial infarction (κ, 0.71-0.74) and excellent for coronary revascularization (κ, 0.88-0.91). The hormone:placebo hazard ratio for clinical myocardial infarction was 1.31 (95% confidence interval, 1.03-1.67) based on WHI outcomes and 1.29 (95% confidence interval, 1.00-1.68) based on Medicare data. The hazard ratio for coronary revascularization was 1.09 (95% confidence interval, 0.88-1.35) based on WHI outcomes and 1.10 (95% confidence interval, 0.89-1.35) based on Medicare data. The differences between hazard ratios derived from WHI and Medicare data were not significant in 1000 bootstrap replications. Medicare claims may provide useful data on coronary heart disease outcomes among patients aged ≥65 years in clinical research studies. URL: www.clinicaltrials.gov. Unique identifier: NCT00000611.
doi_str_mv 10.1161/CIRCOUTCOMES.113.000373
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4548886</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1492674486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-7ce1732316b284d078da2dcc28f9ad5f7affa6fc6d34ca1d5c0ef0f8d0db4a383</originalsourceid><addsrcrecordid>eNpVUV1PGzEQtKpWfJW_0PqtfQm1b53z3QsSOlGIBIrUEvXR2tjrxuhyBttB4t9zEIjgaXdnd2ZHGsa-S3EiZS1_dbM_3Xxx082vz_-OCJwIIUDDJ3YgWyUnWovp510vYZ8d5nwrRA1VDXtsv1LQtgDigOEiE4-eX5MLFhNxhwV5iTw4Gkrwj9zGFAdMj3xFmAp3IRM-czbFxjVlHgZeVsT_jcPwI_NLwr6s-GwIJWAJD_SVffHYZzp-rUds8fv8prucXM0vZt3Z1cQqBWWiLUkNFch6WTXKCd04rJy1VeNbdFOv0Xusva0dKIvSTa0gL3zjhFsqhAaO2OlW926zXJOzo_2EvblLYT26NxGD-bgZwsr8jw9GTVXTNPUo8PNVIMX7DeVi1iFb6nscKG6ykaqtaq3Uy6nentoUc07kd2-kMM8BmfcBjQiYbUAj89t7lzveWyLwBAlvkKg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1492674486</pqid></control><display><type>article</type><title>Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hlatky, Mark A ; Ray, Roberta M ; Burwen, Dale R ; Margolis, Karen L ; Johnson, Karen C ; Kucharska-Newton, Anna ; Manson, JoAnn E ; Robinson, Jennifer G ; Safford, Monika M ; Allison, Matthew ; Assimes, Themistocles L ; Bavry, Anthony A ; Berger, Jeffrey ; Cooper-DeHoff, Rhonda M ; Heckbert, Susan R ; Li, Wenjun ; Liu, Simin ; Martin, Lisa W ; Perez, Marco V ; Tindle, Hilary A ; Winkelmayer, Wolfgang C ; Stefanick, Marcia L</creator><creatorcontrib>Hlatky, Mark A ; Ray, Roberta M ; Burwen, Dale R ; Margolis, Karen L ; Johnson, Karen C ; Kucharska-Newton, Anna ; Manson, JoAnn E ; Robinson, Jennifer G ; Safford, Monika M ; Allison, Matthew ; Assimes, Themistocles L ; Bavry, Anthony A ; Berger, Jeffrey ; Cooper-DeHoff, Rhonda M ; Heckbert, Susan R ; Li, Wenjun ; Liu, Simin ; Martin, Lisa W ; Perez, Marco V ; Tindle, Hilary A ; Winkelmayer, Wolfgang C ; Stefanick, Marcia L</creatorcontrib><description>Data collected as part of routine clinical practice could be used to detect cardiovascular outcomes in pragmatic clinical trials or clinical registry studies. The reliability of claims data for documenting outcomes is unknown. We linked records of Women's Health Initiative (WHI) participants aged ≥65 years to Medicare claims data and compared hospitalizations that had diagnosis codes for acute myocardial infarction or coronary revascularization with WHI outcomes adjudicated by study physicians. We then compared the hazard ratios for active versus placebo hormone therapy based solely on WHI-adjudicated events with corresponding hazard ratios based solely on claims data for the same hormone trial participants. Agreement between WHI-adjudicated outcomes and Medicare claims was good for the diagnosis of myocardial infarction (κ, 0.71-0.74) and excellent for coronary revascularization (κ, 0.88-0.91). The hormone:placebo hazard ratio for clinical myocardial infarction was 1.31 (95% confidence interval, 1.03-1.67) based on WHI outcomes and 1.29 (95% confidence interval, 1.00-1.68) based on Medicare data. The hazard ratio for coronary revascularization was 1.09 (95% confidence interval, 0.88-1.35) based on WHI outcomes and 1.10 (95% confidence interval, 0.89-1.35) based on Medicare data. The differences between hazard ratios derived from WHI and Medicare data were not significant in 1000 bootstrap replications. Medicare claims may provide useful data on coronary heart disease outcomes among patients aged ≥65 years in clinical research studies. URL: www.clinicaltrials.gov. Unique identifier: NCT00000611.</description><identifier>ISSN: 1941-7713</identifier><identifier>EISSN: 1941-7705</identifier><identifier>DOI: 10.1161/CIRCOUTCOMES.113.000373</identifier><identifier>PMID: 24399330</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Aged, 80 and over ; Centers for Medicare and Medicaid Services, U.S. - statistics &amp; numerical data ; Coronary Disease - diagnosis ; Coronary Disease - epidemiology ; Coronary Disease - therapy ; Estrogens - therapeutic use ; Female ; Hormone Replacement Therapy - statistics &amp; numerical data ; Humans ; Insurance Claim Review ; Medicare - statistics &amp; numerical data ; Myocardial Infarction - diagnosis ; Myocardial Infarction - epidemiology ; Myocardial Infarction - therapy ; Patient Outcome Assessment ; Percutaneous Coronary Intervention - statistics &amp; numerical data ; Progestins - therapeutic use ; Prognosis ; Retrospective Studies ; Treatment Outcome ; United States ; Women's Health - statistics &amp; numerical data</subject><ispartof>Circulation Cardiovascular quality and outcomes, 2014-01, Vol.7 (1), p.157-162</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-7ce1732316b284d078da2dcc28f9ad5f7affa6fc6d34ca1d5c0ef0f8d0db4a383</citedby><cites>FETCH-LOGICAL-c443t-7ce1732316b284d078da2dcc28f9ad5f7affa6fc6d34ca1d5c0ef0f8d0db4a383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,3674,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24399330$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hlatky, Mark A</creatorcontrib><creatorcontrib>Ray, Roberta M</creatorcontrib><creatorcontrib>Burwen, Dale R</creatorcontrib><creatorcontrib>Margolis, Karen L</creatorcontrib><creatorcontrib>Johnson, Karen C</creatorcontrib><creatorcontrib>Kucharska-Newton, Anna</creatorcontrib><creatorcontrib>Manson, JoAnn E</creatorcontrib><creatorcontrib>Robinson, Jennifer G</creatorcontrib><creatorcontrib>Safford, Monika M</creatorcontrib><creatorcontrib>Allison, Matthew</creatorcontrib><creatorcontrib>Assimes, Themistocles L</creatorcontrib><creatorcontrib>Bavry, Anthony A</creatorcontrib><creatorcontrib>Berger, Jeffrey</creatorcontrib><creatorcontrib>Cooper-DeHoff, Rhonda M</creatorcontrib><creatorcontrib>Heckbert, Susan R</creatorcontrib><creatorcontrib>Li, Wenjun</creatorcontrib><creatorcontrib>Liu, Simin</creatorcontrib><creatorcontrib>Martin, Lisa W</creatorcontrib><creatorcontrib>Perez, Marco V</creatorcontrib><creatorcontrib>Tindle, Hilary A</creatorcontrib><creatorcontrib>Winkelmayer, Wolfgang C</creatorcontrib><creatorcontrib>Stefanick, Marcia L</creatorcontrib><title>Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative</title><title>Circulation Cardiovascular quality and outcomes</title><addtitle>Circ Cardiovasc Qual Outcomes</addtitle><description>Data collected as part of routine clinical practice could be used to detect cardiovascular outcomes in pragmatic clinical trials or clinical registry studies. The reliability of claims data for documenting outcomes is unknown. We linked records of Women's Health Initiative (WHI) participants aged ≥65 years to Medicare claims data and compared hospitalizations that had diagnosis codes for acute myocardial infarction or coronary revascularization with WHI outcomes adjudicated by study physicians. We then compared the hazard ratios for active versus placebo hormone therapy based solely on WHI-adjudicated events with corresponding hazard ratios based solely on claims data for the same hormone trial participants. Agreement between WHI-adjudicated outcomes and Medicare claims was good for the diagnosis of myocardial infarction (κ, 0.71-0.74) and excellent for coronary revascularization (κ, 0.88-0.91). The hormone:placebo hazard ratio for clinical myocardial infarction was 1.31 (95% confidence interval, 1.03-1.67) based on WHI outcomes and 1.29 (95% confidence interval, 1.00-1.68) based on Medicare data. The hazard ratio for coronary revascularization was 1.09 (95% confidence interval, 0.88-1.35) based on WHI outcomes and 1.10 (95% confidence interval, 0.89-1.35) based on Medicare data. The differences between hazard ratios derived from WHI and Medicare data were not significant in 1000 bootstrap replications. Medicare claims may provide useful data on coronary heart disease outcomes among patients aged ≥65 years in clinical research studies. URL: www.clinicaltrials.gov. Unique identifier: NCT00000611.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Centers for Medicare and Medicaid Services, U.S. - statistics &amp; numerical data</subject><subject>Coronary Disease - diagnosis</subject><subject>Coronary Disease - epidemiology</subject><subject>Coronary Disease - therapy</subject><subject>Estrogens - therapeutic use</subject><subject>Female</subject><subject>Hormone Replacement Therapy - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Insurance Claim Review</subject><subject>Medicare - statistics &amp; numerical data</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Myocardial Infarction - therapy</subject><subject>Patient Outcome Assessment</subject><subject>Percutaneous Coronary Intervention - statistics &amp; numerical data</subject><subject>Progestins - therapeutic use</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>United States</subject><subject>Women's Health - statistics &amp; numerical data</subject><issn>1941-7713</issn><issn>1941-7705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUV1PGzEQtKpWfJW_0PqtfQm1b53z3QsSOlGIBIrUEvXR2tjrxuhyBttB4t9zEIjgaXdnd2ZHGsa-S3EiZS1_dbM_3Xxx082vz_-OCJwIIUDDJ3YgWyUnWovp510vYZ8d5nwrRA1VDXtsv1LQtgDigOEiE4-eX5MLFhNxhwV5iTw4Gkrwj9zGFAdMj3xFmAp3IRM-czbFxjVlHgZeVsT_jcPwI_NLwr6s-GwIJWAJD_SVffHYZzp-rUds8fv8prucXM0vZt3Z1cQqBWWiLUkNFch6WTXKCd04rJy1VeNbdFOv0Xusva0dKIvSTa0gL3zjhFsqhAaO2OlW926zXJOzo_2EvblLYT26NxGD-bgZwsr8jw9GTVXTNPUo8PNVIMX7DeVi1iFb6nscKG6ykaqtaq3Uy6nentoUc07kd2-kMM8BmfcBjQiYbUAj89t7lzveWyLwBAlvkKg</recordid><startdate>201401</startdate><enddate>201401</enddate><creator>Hlatky, Mark A</creator><creator>Ray, Roberta M</creator><creator>Burwen, Dale R</creator><creator>Margolis, Karen L</creator><creator>Johnson, Karen C</creator><creator>Kucharska-Newton, Anna</creator><creator>Manson, JoAnn E</creator><creator>Robinson, Jennifer G</creator><creator>Safford, Monika M</creator><creator>Allison, Matthew</creator><creator>Assimes, Themistocles L</creator><creator>Bavry, Anthony A</creator><creator>Berger, Jeffrey</creator><creator>Cooper-DeHoff, Rhonda M</creator><creator>Heckbert, Susan R</creator><creator>Li, Wenjun</creator><creator>Liu, Simin</creator><creator>Martin, Lisa W</creator><creator>Perez, Marco V</creator><creator>Tindle, Hilary A</creator><creator>Winkelmayer, Wolfgang C</creator><creator>Stefanick, Marcia L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201401</creationdate><title>Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative</title><author>Hlatky, Mark A ; Ray, Roberta M ; Burwen, Dale R ; Margolis, Karen L ; Johnson, Karen C ; Kucharska-Newton, Anna ; Manson, JoAnn E ; Robinson, Jennifer G ; Safford, Monika M ; Allison, Matthew ; Assimes, Themistocles L ; Bavry, Anthony A ; Berger, Jeffrey ; Cooper-DeHoff, Rhonda M ; Heckbert, Susan R ; Li, Wenjun ; Liu, Simin ; Martin, Lisa W ; Perez, Marco V ; Tindle, Hilary A ; Winkelmayer, Wolfgang C ; Stefanick, Marcia L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-7ce1732316b284d078da2dcc28f9ad5f7affa6fc6d34ca1d5c0ef0f8d0db4a383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Centers for Medicare and Medicaid Services, U.S. - statistics &amp; numerical data</topic><topic>Coronary Disease - diagnosis</topic><topic>Coronary Disease - epidemiology</topic><topic>Coronary Disease - therapy</topic><topic>Estrogens - therapeutic use</topic><topic>Female</topic><topic>Hormone Replacement Therapy - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Insurance Claim Review</topic><topic>Medicare - statistics &amp; numerical data</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Myocardial Infarction - therapy</topic><topic>Patient Outcome Assessment</topic><topic>Percutaneous Coronary Intervention - statistics &amp; numerical data</topic><topic>Progestins - therapeutic use</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>United States</topic><topic>Women's Health - statistics &amp; numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hlatky, Mark A</creatorcontrib><creatorcontrib>Ray, Roberta M</creatorcontrib><creatorcontrib>Burwen, Dale R</creatorcontrib><creatorcontrib>Margolis, Karen L</creatorcontrib><creatorcontrib>Johnson, Karen C</creatorcontrib><creatorcontrib>Kucharska-Newton, Anna</creatorcontrib><creatorcontrib>Manson, JoAnn E</creatorcontrib><creatorcontrib>Robinson, Jennifer G</creatorcontrib><creatorcontrib>Safford, Monika M</creatorcontrib><creatorcontrib>Allison, Matthew</creatorcontrib><creatorcontrib>Assimes, Themistocles L</creatorcontrib><creatorcontrib>Bavry, Anthony A</creatorcontrib><creatorcontrib>Berger, Jeffrey</creatorcontrib><creatorcontrib>Cooper-DeHoff, Rhonda M</creatorcontrib><creatorcontrib>Heckbert, Susan R</creatorcontrib><creatorcontrib>Li, Wenjun</creatorcontrib><creatorcontrib>Liu, Simin</creatorcontrib><creatorcontrib>Martin, Lisa W</creatorcontrib><creatorcontrib>Perez, Marco V</creatorcontrib><creatorcontrib>Tindle, Hilary A</creatorcontrib><creatorcontrib>Winkelmayer, Wolfgang C</creatorcontrib><creatorcontrib>Stefanick, Marcia L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Circulation Cardiovascular quality and outcomes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hlatky, Mark A</au><au>Ray, Roberta M</au><au>Burwen, Dale R</au><au>Margolis, Karen L</au><au>Johnson, Karen C</au><au>Kucharska-Newton, Anna</au><au>Manson, JoAnn E</au><au>Robinson, Jennifer G</au><au>Safford, Monika M</au><au>Allison, Matthew</au><au>Assimes, Themistocles L</au><au>Bavry, Anthony A</au><au>Berger, Jeffrey</au><au>Cooper-DeHoff, Rhonda M</au><au>Heckbert, Susan R</au><au>Li, Wenjun</au><au>Liu, Simin</au><au>Martin, Lisa W</au><au>Perez, Marco V</au><au>Tindle, Hilary A</au><au>Winkelmayer, Wolfgang C</au><au>Stefanick, Marcia L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative</atitle><jtitle>Circulation Cardiovascular quality and outcomes</jtitle><addtitle>Circ Cardiovasc Qual Outcomes</addtitle><date>2014-01</date><risdate>2014</risdate><volume>7</volume><issue>1</issue><spage>157</spage><epage>162</epage><pages>157-162</pages><issn>1941-7713</issn><eissn>1941-7705</eissn><abstract>Data collected as part of routine clinical practice could be used to detect cardiovascular outcomes in pragmatic clinical trials or clinical registry studies. The reliability of claims data for documenting outcomes is unknown. We linked records of Women's Health Initiative (WHI) participants aged ≥65 years to Medicare claims data and compared hospitalizations that had diagnosis codes for acute myocardial infarction or coronary revascularization with WHI outcomes adjudicated by study physicians. We then compared the hazard ratios for active versus placebo hormone therapy based solely on WHI-adjudicated events with corresponding hazard ratios based solely on claims data for the same hormone trial participants. Agreement between WHI-adjudicated outcomes and Medicare claims was good for the diagnosis of myocardial infarction (κ, 0.71-0.74) and excellent for coronary revascularization (κ, 0.88-0.91). The hormone:placebo hazard ratio for clinical myocardial infarction was 1.31 (95% confidence interval, 1.03-1.67) based on WHI outcomes and 1.29 (95% confidence interval, 1.00-1.68) based on Medicare data. The hazard ratio for coronary revascularization was 1.09 (95% confidence interval, 0.88-1.35) based on WHI outcomes and 1.10 (95% confidence interval, 0.89-1.35) based on Medicare data. The differences between hazard ratios derived from WHI and Medicare data were not significant in 1000 bootstrap replications. Medicare claims may provide useful data on coronary heart disease outcomes among patients aged ≥65 years in clinical research studies. URL: www.clinicaltrials.gov. Unique identifier: NCT00000611.</abstract><cop>United States</cop><pmid>24399330</pmid><doi>10.1161/CIRCOUTCOMES.113.000373</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1941-7713
ispartof Circulation Cardiovascular quality and outcomes, 2014-01, Vol.7 (1), p.157-162
issn 1941-7713
1941-7705
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4548886
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Aged
Aged, 80 and over
Centers for Medicare and Medicaid Services, U.S. - statistics & numerical data
Coronary Disease - diagnosis
Coronary Disease - epidemiology
Coronary Disease - therapy
Estrogens - therapeutic use
Female
Hormone Replacement Therapy - statistics & numerical data
Humans
Insurance Claim Review
Medicare - statistics & numerical data
Myocardial Infarction - diagnosis
Myocardial Infarction - epidemiology
Myocardial Infarction - therapy
Patient Outcome Assessment
Percutaneous Coronary Intervention - statistics & numerical data
Progestins - therapeutic use
Prognosis
Retrospective Studies
Treatment Outcome
United States
Women's Health - statistics & numerical data
title Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T00%3A28%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20Medicare%20data%20to%20identify%20coronary%20heart%20disease%20outcomes%20in%20the%20Women's%20Health%20Initiative&rft.jtitle=Circulation%20Cardiovascular%20quality%20and%20outcomes&rft.au=Hlatky,%20Mark%20A&rft.date=2014-01&rft.volume=7&rft.issue=1&rft.spage=157&rft.epage=162&rft.pages=157-162&rft.issn=1941-7713&rft.eissn=1941-7705&rft_id=info:doi/10.1161/CIRCOUTCOMES.113.000373&rft_dat=%3Cproquest_pubme%3E1492674486%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1492674486&rft_id=info:pmid/24399330&rfr_iscdi=true